The enzyme 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) is a key enzyme in the methylerythritol 4-phosphate pathway and is a target for the development of antibiotics, herbicides, and antimalarial drugs. DXPS catalyzes the formation of 1-deoxy-D-xylulose 5-phosphate (DXP), a branch point metabolite in isoprenoid biosynthesis, and is also used in the biosynthesis of thiamin (vitamin B 1 ) and pyridoxal (vitamin B 6 ). Previously, we found that DXPS is unique among the superfamily of thiamin diphosphate (ThDP)-dependent enzymes in stabilizing the predecarboxylation intermediate, C2-alpha-lactylthiamin diphosphate (LThDP), which has subsequent decarboxylation that is triggered by D-glyceraldehyde 3-phosphate (GAP). Herein, we applied hydrogen-deuterium (H/D) exchange MS (HDX-MS) of fulllength Escherichia coli DXPS to provide a snapshot of the conformational dynamics of this enzyme, leading to the following conclusions. (i) The high sequence coverage of DXPS allowed us to monitor structural changes throughout the entire enzyme, including two segments (spanning residues 183-238 and 292-317) not observed by X-ray crystallography. (ii) Three regions of DXPS (spanning residues 42-58, 183-199, and 278-298) near the active center displayed both EX1 (monomolecular) and EX2 (bimolecuar) H/D exchange (HDX) kinetic behavior in both ligand-free and ligand-bound states. All other peptides behaved according to the common EX2 kinetic mechanism. (iii) The observation of conformational changes on DXPS provides support for the role of conformational dynamics in the DXPS mechanism: The closed conformation of DXPS is critical for stabilization of LThDP, whereas addition of GAP converts DXPS to the open conformation that coincides with decarboxylation of LThDP and DXP release.
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DXP synthase | conformational dynamics | H/D exchange MS | ThDP-dependent enzymes | EX1 kinetics T he enzyme 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) is a key enzyme in the methylerythritol 4-phosphate pathway and is a target for development of antibiotics, herbicides, and antimalarial drugs. DXPS catalyzes the formation of 1-deoxy-D-xylulose 5-phosphate (DXP), a branch point metabolite in isoprenoid biosynthesis, and is also used in the biosynthesis of thiamin (vitamin B 1 ) and pyridoxal (vitamin B 6 ) ( Fig. 1) , all of which are essential for bacterial growth and survival (1) (2) (3) (4) . Because of the increasing spread of drug resistance by virulent species, identification of new molecular targets becomes critical (5) (6) (7) (8) (9) (10) (11) (12) . DXPS as a thiamin diphosphate (ThDP)-dependent 2-oxo acid decarboxylase proceeds via a number of covalent ThDP-bound intermediates with its first substrate pyruvate (Py) (Fig. S1 ) (13) . After decarboxylation of Py has taken place, DXPS catalyzes the subsequent carboligation to D-glyceraldehyde 3-phosphate (GAP) forming DXP, reminiscent of the reactions of essential mammalian enzymes, such as transketolase. Previous mechanistic and structural studies have uncovered several distinguishing features of DXPS among the superfamily of ThDP-dependent enzymes (12) (13) (14) (15) (16) (17) . Unlike the classical ping-pong mechanism exhibited by other ThDP-dependent enzymes, DXPS catalyzes a random sequential, preferred order mechanism, which is unprecedented in ThDP-dependent enzymology (13) (14) (15) (16) (17) . The unique feature of DXPS is a stabilization of the enzyme-bound tetrahedral predecarboxylation intermediate, C2-alpha-lactyl-thiamin diphosphate (LThDP), formed on Py binding (Fig. S1 ). Formation of a ternary complex on GAP binding is required to trigger decarboxylation of LThDP (13) . Accordingly, DXPS possesses a large active site, presumably to accommodate ternary complex formation (10) . Two structures of DXPS (from Escherichia coli and Deinococcus radiodurans) have been reported so far (18) . The structural studies revealed a dimer organization in DXPS, where the active site is located at the interface between domains I and II within the same monomer of the DXPS dimer, in contrast to other ThDP enzymes, which have active centers that are located at the interface between two monomers (18) . Because of the in situ proteolysis required for crystallization of the E. coli DXPS, leading to removal of two important segments spanning residues 183-238 (located near the active site) and 292-317 (linker between domain I and domain II, forming the active center), alternative approaches are desirable to gain additional structurefunction insight.
This hydrogen-deuterium exchange MS (HDX-MS) study provides a snapshot of the conformational dynamics of the fulllength E. coli DXPS (it is a dimer of 629 amino acids per subunit), dynamics proposed earlier by our own studies (13, 16) and by others (19) . Of all 56 peptides resulting from pepsin digestion of DXPS (93.7% coverage), only three segments near the active center indicated differential deuterium uptake, two segments of which were not observed in the X-ray structure (18) . Equally striking, only those three segments responded to addition of a
Significance
We applied hydrogen-deuterium exchange MS to a study of fulllength Escherichia coli 1-deoxy-D-xylulose 5-phosphate synthase (DXPS), a key enzyme in the methylerythritol 4-phosphate pathway, to provide a snapshot of its conformational dynamics. The three regions displaying an EX1 (monomolecular) exchange behavior, two of which are absent in the X-ray structure, were shown to be dynamic. Open and closed conformations of those regions were revealed with no ligand bound; with substrate analogue bound, a closed conformation was favored, while addition of the second substrate D-glyceraldehyde 3-phosphate and product 1-deoxy-D-xylulose 5-phosphate induced the open conformation, suggesting crucial roles of conformational changes in the mechanism. Our findings revealed a role for active center loops on DXPS, a mechanistically unique thiamin diphosphatedependent enzyme. stable Py analog, methyl acetylphosphonate (a known inhibitor of ThDP-dependent enzymes), GAP, or DXP. In the absence of ligands, these regions of DXPS display a bimodal pattern of deuterium uptake, implying EX1 (monomolecular) H/D exchange (HDX) kinetic behavior, in addition to the more common EX2 (bimolecuar) kinetics (20) (21) (22) (23) . Although the rates of deuterium uptake are unaffected by ligand binding, the rates of unfolding in the regions displaying EX1 kinetics are ligand-dependent, suggesting that the closed conformation of DXPS in the presence of the stable substrate analog methyl acetylphosphonate is distinct from the conformational changes, leading to an open conformation induced by GAP and DXP. The observation of conformational changes induced on DXPS by GAP binding provides the highest resolution data reported to date to support the role of conformational dynamics in the DXPS mechanism and suggests that a GAP-induced opening of the active site loops is important in the unique mechanism of LThDP decarboxylation.
Results and Discussion
Both EX1 and EX2 Exchange Kinetics Are Needed to Interpret HDX Experiments on DXPS. Two mechanisms have been proposed to explain HDX under physiological conditions in proteins. The first one suggests that exchange may occur from the closed form, and the second one suggests that partial local unfolding occurs before exchange can take place (24, 25) . Under physiological conditions, the second mechanism (Eq. 1) appears to be the predominant pathway for HDX in proteins:
[1]
As illustrated in Eq. 1, there are three steps involved in backbone amide hydrogen exchange in proteins. To exchange H for D, the closed conformation F H is converted to the open conformation U H . This unfolding process exposes backbone amide hydrogens, which can subsequently undergo exchange with deuterium oxide. The rate constants k 1 , k −1 , and k ex describe the kinetics of unfolding, refolding, and hydrogen exchange steps, respectively The centroid masses of lower (red traces) and higher (blue traces) mass envelopes were fit and calculated individually. Since the centroid mass of lower mass envelope also changes with increasing exposure time, the displayed kinetics is likely a mixture of EX1 and EX2 kinetics. (D and E) The deuterium uptake plots for regions comprising residues 183-238 and 292-317, which are missing from the crystal structure (18) . (F) The average percentage of deuterium incorporation at the 30-min time point is mapped onto the crystal structure of E. coli DXPS. For clarity, percentage deuterium uptake is represented for one DXPS monomer, while the other monomer is shown in yellow. (24) . The hydrogen exchange in this model can be described by two different kinetic regimes, EX1 and EX2. When the exchange is governed by EX1 kinetics, the unfolding rate is much faster than the refolding rate (k 1 >> k −1 ). Under these conditions, all of the amide hydrogens exchange with deuterium in the open state before refolding occurs. As a result, EX1 kinetics gives rise to two distinct mass envelopes. The lower mass envelope represents the closed (F H ; undeuterated) state, and the higher mass envelope represents the open (U D ; deuterated) state. In EX2 kinetics, the protein refolding rate is much faster than the unfolding rate (k 1 << k −1 ); therefore, the unfolding has to occur multiple times before a successful exchange reaction takes place. EX2 kinetics leads to a single isotopic distribution, which gradually shifts to a higher m/z range over time. While the majority of proteins behave according to EX2 kinetics under physiological conditions, there are increasing numbers of examples reporting proteins with EX1 kinetic behavior. The EX1 behavior must be confirmed by rigorous control experiments, thoroughly described by Engen and coworkers (26) . We present such key control experiments in SI Materials and Methods (noted throughout Results and Discussion and in SI Materials and Methods) to rule out commonly observed erroneous assignment of EX1 behavior (such as aggregation/multimerization, carryover between runs, having multiple proteins, and abnormal complete back exchange). It is concluded that, under the experimental conditions used, we can indeed attribute the findings to EX1 kinetic behavior in the three regions of DXPS identified, which could provide important insights into the conformational dynamics of DXPS along its reaction coordinate.
Overview of HDX Patterns on Full-Length DXPS. Online digestion of DXPS by pepsin followed by liquid chromatography-mass spectrometry (LC-MS) analysis under the selected HDX conditions yielded 56 peptides, many of which were partially overlapping, providing 93.7% sequence coverage ( Fig. S2 and Table S1 ). The redundancy of peptides detected provides an internal control for consistency of sequence assignment. Throughout the entire protein, overlapping peptides display similar HDX kinetics. While most of the overlapping peptides of DXPS display EX2 exchange kinetics exclusively, there are three distinct regions of the protein in which each of the overlapping peptides (such as 42-56 and 51-58 along with 188-196 and 183-199) is characterized by EX1 kinetics (results reported below). These observations serve as an internal control to prevent false EX1 assignment (SI Materials and Methods has additional support). Importantly, the high sequence coverage achieved in this study allowed us to monitor structural changes throughout most of the protein, including segments 183-238 and 292-317, which are not observed in the available crystal structure of E. coli DXPS (18) .
The average deuterium uptake percentage by key peptides of DXPS over 30 min of exchange (20 s and 1, 2, 3, 5, 10, and 30 min) is illustrated in Fig. 2 , including peptides 183-199 (missing in segment 183-238) and 299-329 (missing in segment 292-317) (Fig. 2 A-E) . The overall deuterium incorporation was low; many regions underwent less than 35% deuteration over a 30-min exchange (Figs. 2F and 3A) . The deuterium incorporation pattern clearly indicates that the greatest extent of HDX occurs in domain I (residues 1-319), suggesting that this is the most dynamic of the three domains of the DXPS monomer. In contrast, the areas with the least extent of deuterium incorporation are located in domains II (residues 320-495) and III (residues 496-629) (Fig. 3A) .
HDX-MS Detects Local Structural Dynamics of DXPS.
The conformational flexibility of full-length DXPS in the absence of ligands was examined (Figs. 2 A-C and 3B ). Deuterium uptake for most peptides identified under the HDX conditions used revealed a single isotopic distribution that increased in mass over time, suggesting that these regions display the more common EX2 kinetic behavior. Notably, three regions (42-58, 183-199, and 278-298) (Figs. 3B and 4 and Figs. S3-S6) displayed a bimodal isotopic distribution, consistent with EX1 kinetics. Because peptides 42-56 and 51-58 have overlapping residues, they will be referred to as peptides 42-58 in the following discussion. Addition of the ligands selected for this study had little effect on the deuterium incorporation by the peptides of DXPS that were characterized by EX2 kinetics (Fig. S2) . Regions that were affected by the addition of ligands were those that display EX1 kinetics (Figs. S3-S7) . Notably, unlike most of the reported bimodal patterns, which are induced on adding a binding partner (27, 28) , the bimodal patterns of these three regions are displayed by DXPS, even in the absence of bound ligands. Although segments with corresponding residues 183-199 and 292-298 (part of the 278-298 peptide) are missing from the crystal structure, the positions of the adjacent N-terminal residues of these peptides (which are observed in the crystal structure) suggest that the three regions displaying EX1 kinetics are close to each other in space (Fig. 5) . Given their close spatial proximity to one another and to the active site, it is possible that the conformational changes accounting for the observed EX1 kinetics occur simultaneously in all three regions (Fig. 5) .
We considered possible explanations for our observation of the bimodal distribution that could result from EX1 kinetics on DXPS, in which two distinct conformations interconvert during the HDX incubation period. In this case, it seems that the equilibration rate between closed and open conformations of the corresponding peptide is slower than the HDX rate, which indicates that both conformations are fairly stable under physiological conditions. A plausible explanation for the EX1 kinetic behavior of the three regions is that the two active centers of DXPS homodimer are asymmetric by virtue of the different tautomeric forms of 4′-aminopyrimidine ring of ThDP occupying two active centers, as we observed on two other ThDP enzymes which decarboxylate Py [for example, CD studies of Py oxidase from Lactobacillus plantarum and of human pyruvate dehydrogenase complex (PDHc) E1 component displaying simultaneously both the 1′,4′-iminopyrimidine and the 4′-aminopyrimidine ThDP tautomers (29)], but not yet established on DXPS. Although this could explain the EX1 kinetics found in this study, it cannot explain the changes of relative abundance of the two isotopic distributions over time. Given the observation that segments with corresponding residues 183-238 and 292-317 were missing in the DXPS structures from E. coli (18) , an alternative explanation for the observation of the EX1 kinetics is that the dynamic nature of these two regions may be responsible for the localized folding/ unfolding event. As DXPS is the first ThDP-dependent enzyme to display this behavior, the findings suggest that this conformational flexibility may have an important role in the unusual mechanism catalyzed by DXPS.
Careful examination of the three regions displaying EX1 kinetics in the absence of ligand revealed several unusual behaviors. First, these three regions all adopted mixed EX1/EX2 kinetics. In addition to the distinct bimodal EX1 signature described above, the lower mass envelope of each peptide was gradually converted to the high mass range over time (Figs. 3B and 4 and Figs. S3-S6). As these peptides are long, they may in part undergo HDX via the EX1 mechanism and in part via the EX2 mechanism. Second, the higher mass envelope of all peptides was maximally labeled (40% deuteration for peptides 42-56, 63% for 183-199, and 36% for 278-298) by the 20-s time point. The centroid mass difference of higher and lower mass envelopes at the 20-s time point indicated a 4-Da difference in peptides 42-56 (30.8% of residues), an 8-Da difference in peptides 183-199 (53.5% of residues), and a 6-Da difference in peptides 278-298 (35.3% of the residues) being involved in the unfolding event (Fig. 2 A-C) . Fig. S1 ) that could be observed by CD spectroscopy (Fig. S8) (6, 15, 30, 31) . The formation of the predecarboxylation intermediate mimic PLThDP before HDX significantly slows down the unfolding of all three EX1 signature peptides with residues 42-58, 183-199, and 278-298. The slowdown is apparent in the HDX-MS spectra (Fig. 4, Table 1 , and Figs. S3-S6), where a bimodal distribution is observed but with a greater contribution from the lower mass envelope relative to DXPS by itself. This phenomenon can be quantified by the "slowdown factor" (22) , which is calculated using the rate constant (k u ) or half-life (t 1/2 ) for unfolding. The slowdown factor is simply the t 1/2 of unfolding in the presence of ligand divided by the t 1/2 of unfolding in the absence of ligand. A summary of the unfolding rate constants, half-lives, and slowdown factors of each of the peptides exhibiting an EX1 signature is presented in Table 1 . It is clear that methyl acetylphosphonate gives rise to the most pronounced slowdown factor. A likely I-TASSER (33, 34) . E. coli DXPS structure (Protein Data Bank ID code 2o1s) was assigned as a restraint and template to guide I-TASSER modeling. Table 1 . Rate constant of unfolding and the unfolding half-life and slowdown factor (SD) of the three regions displaying EX1 kinetics
Regions Peptides 42-56
Peptides 183-199 Peptides 278-298 The HDX behaviors of DXPS in the presence of GAP, GAP + methyl acetylphosphonate, or DXP were also examined. On binding of GAP or DXP to DXPS, the regions 42-58, 183-199, and 278-298 display unique unfolding events as shown in Fig. 4 and Figs. S3-S6. The increased abundance of the higher mass envelope of the bimodal distribution suggests that both GAP and DXP could induce conformational changes in the regions displaying EX1 behavior, resulting in the formation of an open conformation. As shown in Table 1 , the half-life of unfolding is shorter on all peptides compared with DXPS in the absence of ligand; however, these rates of unfolding are still significantly longer than those observed in the presence of methyl acetylphosphonate. We next examined the role of GAP to induce a conformational rearrangement of DXPS subsequent to methyl acetylphosphonate binding to model events in the ternary complex leading to GAP-induced LThDP decarboxylation.
The HDX-MS behavior of DXPS with methyl acetylphosphonate bound was compared in the absence and presence of GAP. All peptides consistently exhibited EX1 kinetics profiles as induced by methyl acetylphosphonate, even in the presence of GAP. However, a modest increase was observed in the isotopic distribution favoring the higher mass envelope of all peptides exhibiting EX1 kinetics in the presence of GAP compared with the observation in the presence of methyl acetylphosphonate (Fig. 4 and Figs. S3-S6) . Accordingly, the rates of unfolding of the three peptides exhibiting EX1 kinetics were found to be about two to three times faster than with methyl acetylphosphonate alone (Table 1) . Importantly, these results provide additional evidence for the unique ability of GAP to trigger conformation changes on DXPS both in the absence and presence of a donor substrate mimic. This is consistent with a model (Fig. 6) , in which LThDP is stabilized in the closed conformation before binding of GAP. 
Conclusion
This study has marked an important step forward in our understanding of the mechanism of DXPS. The HDX-MS data reveal the most detailed insight to date on the DXPS dynamics in response to the binding of methyl acetylphosphonate, a stable mimic of Py, of the second substrate GAP and of the DXP product. The high sequence coverage of DXPS in the reported experiments (93.7%) enabled us to study the flexibility over most of the enzyme, including the two segments (183-238 and 292-317), which were missing in the X-ray structure of the E. coli DXPS (18) .
The HDX-MS data showed that domain I of DXPS (residues 1-319) displays unusual conformational flexibility that seems to play important roles in substrate recognition. Three regions (with residues 42-58, 183-199, and 278-298) near the active center displayed an EX1 kinetic signature in both ligand-free and ligand-bound states, and the half-lives of unfolding of these peptides were different depending on the identity of the ligand-DXPS complex. Among those peptides displaying EX1 kinetics, DXPS seems to favor a closed conformation in the presence of methyl acetylphosphonate, a Py mimic, while it favors the open conformation on binding the second substrate GAP or the DXP product. Thus, we propose that the closed conformation of the active center of DXPS is critical for stabilization of the predecarboxylation intermediate (LThDP-DXPS complex) , while the open conformation may play a role in the GAP-triggered decarboxylation of LThDP and in product release. Intriguingly, the EX1 exchange kinetics displayed by DXPS seems to be a unique characteristic of this enzyme compared with other ThDP enzymes examined so far. Although methyl acetylphosphonateinduced conformational changes have also been observed on the E. coli PDHc E1 component (31) , the specific dynamics reported in this study on formation of the PLThDP intermediate on DXPS are unique.
These findings reveal a role for active center loops in DXPS catalysis, supporting the distinct mechanism of DXPS among the ThDP superfamily of enzymes. Two active center loops in the human PDHc E1 component serve as the regulatory phosphorylation sites for the four PDHc kinases (32) , while in the E. coli PDHc, two active center loops facilitate E1-E2 intercomponent communication (30, 31) . Our findings reveal a role for active center loops on DXPS, a mechanistically unique ThDP-dependent enzyme: substrate-induced conformational changes of the loops to advance the reaction sequence, which in the absence of the GAP-induced conformational change, would be terminated at LThDP, the covalent predecarboxylation intermediate.
Materials and Methods
DXPS sample preparation for the HDX-MS and the LC-MS method is presented in SI Materials and Methods. Control experiments supporting the assignment of EX1 kinetic behavior to three regions of DXPS experiencing conformational dynamics are provided in SI Materials and Methods. Finally, CD experimental evidence is provided for specific and tight binding of methyl acetylphosphonate to DXPS in Fig. S8 , results that are in accordance with data published by our groups earlier (6, 15, 30) .
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